Literature DB >> 23535407

Gene expression of epigenetic regulatory factors related to primary silencing mechanism is less susceptible to lower doses of bisphenol A in embryonic hypothalamic cells.

Katsuhiko Warita1, Tomoko Mitsuhashi, Ken-ichi Ohta, Shingo Suzuki, Nobuhiko Hoshi, Takanori Miki, Yoshiki Takeuchi.   

Abstract

DNA methyltransferases (DNMTs) are associated with epigenetic regulation of gene expression, and methyl-CpG binding protein 2 (MECP2) acts as a long-range regulator of methylated genes. We evaluated the effects of bisphenol A (BPA) on embryonic mouse hypothalamic cells, with particular emphasis on the gene expression of Dnmts (Dnmt1, Dnmt3a, and Dnmt3b) and Mecp2 isoforms. In a dose-dependent (0.02-200 µM BPA) 3-hr experiment, real-time reverse transcription polymerase chain reaction revealed that gene expression of both Dnmts and Mecp2_e2 was affected at 200 µM and that of Mecp2_e1 was affected at > 20 µM. These results suggest that gene expression of Dnmts and Mecp2 are less susceptible to lower doses of BPA in developing hypothalamic cells. However, as BPA concentration increases, this agent has the potential to alter gene expression of key players that provide stability and flexibility of epigenetic gene regulation, which could disrupt the normal development of hypothalamic functions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23535407     DOI: 10.2131/jts.38.285

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  15 in total

Review 1.  Induction of oxidative stress by bisphenol A and its pleiotropic effects.

Authors:  Natalie R Gassman
Journal:  Environ Mol Mutagen       Date:  2017-02-09       Impact factor: 3.216

Review 2.  Epigenetic impacts of endocrine disruptors in the brain.

Authors:  Deena M Walker; Andrea C Gore
Journal:  Front Neuroendocrinol       Date:  2016-09-20       Impact factor: 8.606

Review 3.  Rett syndrome and MeCP2.

Authors:  Vichithra R B Liyanage; Mojgan Rastegar
Journal:  Neuromolecular Med       Date:  2014-03-11       Impact factor: 3.843

Review 4.  Bisphenol A co-exposure effects: a key factor in understanding BPA's complex mechanism and health outcomes.

Authors:  Manoj Sonavane; Natalie R Gassman
Journal:  Crit Rev Toxicol       Date:  2019-07-01       Impact factor: 5.635

5.  Histone deacetylase 2 inhibitor valproic acid attenuates bisphenol A-induced liver pathology in male mice.

Authors:  Mohamed A Al-Griw; Zaynab Osama Alshibani; Rabia Alghazeer; Mohamed Elhensheri; Refaat M Tabagh; Areej A Eskandrani; Wafa S Alansari; Mahmoud M Habibulla; Ghalia Shamlan
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

6.  Gene expression and DNA methylation changes in the hypothalamus and hippocampus of adult rats developmentally exposed to bisphenol A or ethinyl estradiol: a CLARITY-BPA consortium study.

Authors:  Ana Cheong; Sarah A Johnson; Emily C Howald; Mark R Ellersieck; Luísa Camacho; Sherry M Lewis; Michelle M Vanlandingham; Jun Ying; Shuk-Mei Ho; Cheryl S Rosenfeld
Journal:  Epigenetics       Date:  2018-08-15       Impact factor: 4.528

Review 7.  Epigenetic Regulation of Non-Lymphoid Cells by Bisphenol A, a Model Endocrine Disrupter: Potential Implications for Immunoregulation.

Authors:  Deena Khan; S Ansar Ahmed
Journal:  Front Endocrinol (Lausanne)       Date:  2015-06-05       Impact factor: 5.555

Review 8.  Bisphenol A and phthalate endocrine disruption of parental and social behaviors.

Authors:  Cheryl S Rosenfeld
Journal:  Front Neurosci       Date:  2015-03-03       Impact factor: 4.677

Review 9.  Bisphenol A Interaction With Brain Development and Functions.

Authors:  P Negri-Cesi
Journal:  Dose Response       Date:  2015-06-17       Impact factor: 2.658

10.  Decitabine alters the expression of Mecp2 isoforms via dynamic DNA methylation at the Mecp2 regulatory elements in neural stem cells.

Authors:  Vichithra R B Liyanage; Robby M Zachariah; Mojgan Rastegar
Journal:  Mol Autism       Date:  2013-11-15       Impact factor: 7.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.